AVR 1.73% $17.05 anteris technologies ltd

Ann: Anti-Calcification Study, page-38

  1. 970 Posts.
    lightbulb Created with Sketch. 25
    Reading up on the Edwards "Resilia" valve. Looks like Dr Bart Meuris is also involved in trials of this valve.
    A trial in sheep showed reduced calcification up to 72%
    There hasn't been any mentions of this valve in Wayne's recent presentations.

    "RESILIA tissue demonstrated, in a large pre-clinical randomized control trial conducted in juvenile sheep in mitral position, to significantly reduce tissue calcification (− 72%) and even to improve haemodynamic performance compared with the Perimount valve [16]. The RESILIA tissue also has been studied in two clinical trials to date [17, 18]. Bartus et al. found, in a single-arm observational study of 133 patients, that the RESILIA tissue provided excellent performance and safety without structural valve deterioration (SVD) [18,19,20]. In the COMMENCE trial [17, 20], 679 patients underwent Carpentier-Edwards PERIMOUNT Magna Ease™ aortic valve replacement with RESILIA™ tissue (Model 11000A) and similar excellent safety and effectiveness were demonstrated for up to 4 years without SVD. Both of these trials have included relatively young patients, with a mean age between 65 and 67 years and up to 26% of patients aged less than 60 years."

    https://cardiothoracicsurgery.biomedcentral.com/articles/10.1186/s13019-020-01155-6

 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
(20min delay)
Last
$17.05
Change
-0.300(1.73%)
Mkt cap ! $327.7M
Open High Low Value Volume
$17.00 $17.44 $16.95 $184.6K 10.84K

Buyers (Bids)

No. Vol. Price($)
1 191 $17.15
 

Sellers (Offers)

Price($) Vol. No.
$17.50 500 1
View Market Depth
Last trade - 15.59pm 19/07/2024 (20 minute delay) ?
AVR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.